AI-generated summary
The authors report a single-arm pilot study in 20 people with Parkinson's disease who received two hours of morning lighting daily for four weeks, via home lamps or light therapy glasses. Objective sleep duration and sleep time increased over the intervention compared with baseline. The study had no control group, and the authors describe the lighting as promising rather than proven.
- Participants
- 20
- Who or what was studied
- People with Parkinson's disease (12 women, 8 men; mean age 72.1 years)
- Limits stated in the abstract
- The single-arm design without a control group and the small pilot sample limit the strength of any conclusions about effectiveness.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.